S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 140.2 SEK 1.37%
Market Cap: 7.2B SEK
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one SUS stock under the Base Case scenario is 217.19 SEK. Compared to the current market price of 140.2 SEK, Surgical Science Sweden AB is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SUS Relative Value
Base Case
217.19 SEK
Undervaluation 35%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

8.1
P/S
P/S
Price to Sales
8.1
vs History
85
vs Industry
17
Median 3Y
9.8
Median 5Y
12
Industry
2.2
Forward
6.2
More Details
54.3
P/E
P/E
Price to Earnings
54.3
vs History
55
vs Industry
9
Median 3Y
44.2
Median 5Y
60.5
Industry
21.9
Forward
36.2
More Details
52.1
P/OCF
P/OCF
Price to OCF
52.1
vs History
61
vs Industry
6
Median 3Y
52.6
Median 5Y
62.9
Industry
13.5
More Details
22.2
P/FCFE
P/FCFE
Price to FCFE
22.2
vs History
76
vs Industry
21
Median 3Y
61.7
Median 5Y
61.2
Industry
19.3
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
85
vs Industry
53
Median 3Y
1.8
Median 5Y
2.1
Industry
2.1
More Details
7
EV/S
EV/S
Enterprise Value to Sales
7
vs History
85
vs Industry
18
Median 3Y
8.9
Median 5Y
11.4
Industry
2.3
Forward
5.4
More Details
10.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.3
vs History
85
vs Industry
21
Median 3Y
13.3
Median 5Y
16.9
Industry
4.8
More Details
30.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30.2
vs History
92
vs Industry
7
Median 3Y
39.7
Median 5Y
56.9
Industry
11.5
Forward
20.7
More Details
42.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
42.9
vs History
76
vs Industry
10
Median 3Y
45.8
Median 5Y
56.9
Industry
15.6
Forward
26.3
More Details
45.1
EV/OCF
EV/OCF
Enterprise Value to OCF
45.1
vs History
69
vs Industry
7
Median 3Y
49.2
Median 5Y
57.2
Industry
13.3
More Details
69
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
69
vs History
58
vs Industry
6
Median 3Y
67.5
Median 5Y
80.3
Industry
17.3
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
87
vs Industry
49
Median 3Y
1.7
Median 5Y
2.1
Industry
1.8
More Details

Multiples Across Competitors

SUS Competitors Multiples
Surgical Science Sweden AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Surgical Science Sweden AB
STO:SUS
7.2B SEK 8.1 54.3 30.2 42.9
US
Abbott Laboratories
NYSE:ABT
230.4B USD 5.4 17.1 22.2 31.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.9B USD 21.7 76.3 60.9 73.3
US
Boston Scientific Corp
NYSE:BSX
153.5B USD 8.7 75.5 35.6 49.4
US
Stryker Corp
NYSE:SYK
144.3B USD 6.2 50.5 25 30.1
IE
Medtronic PLC
NYSE:MDT
105.6B USD 3.2 24.8 13.3 18.8
DE
Siemens Healthineers AG
XETRA:SHL
53B EUR 2.3 26.7 15.4 22
US
Becton Dickinson and Co
NYSE:BDX
47.3B USD 2.3 31.2 12.6 23.6
US
Edwards Lifesciences Corp
NYSE:EW
44.1B USD 8 10.5 24.1 26.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.2B USD 9.7 42.7 30.4 33.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
267B CNY 7.5 24 20.9 20.9

See Also

Summary
SUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
SUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SUS stock valuation using valuation multiples.
Wall Street Estimates
SUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.